Pea and luteolin for recovery after a first stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a combination of two natural substances, palmitoylethanolamide (PEA) and luteolin, can help people who are recovering from a severe first stroke. The treatment is taken by mouth and is meant to reduce inflammation in the brain after a clot is removed, with the goal of improving recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 60 years of age or older.
- You must be having your first-ever stroke — no previous strokes or mini-strokes.
- The stroke must be caused by a blockage in the middle cerebral artery, confirmed by imaging (angio-CT and CTP).
- You must be eligible for mechanical thrombectomy (a procedure to remove the clot) within the guideline-approved time window.
- Your stroke must be severe enough (NIHSS score greater than 6).
- You must not have certain other conditions, such as dementia, Parkinson's, psychiatric disorders, chronic inflammatory diseases, active cancer, or severe swallowing problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether tirzepatide, a medication typically used for diabetes, can improve recovery after a stroke caused by a blocked artery in the brain that was treated with a clot-removal procedure. It may help reduce further damage and support better outcomes.
This trial tests whether stem cell-derived extracellular vesicles can help people recover after a moderate to severe stroke. You may join if you had a stroke in the last 5 days and still have arm or leg weakness, even after standard treatments like clot-busting drugs or clot removal.
This trial tests a plant-based medicine called galantamine, given within 3 days of an ischemic stroke, to see if it helps recovery. It combines Western and Traditional Chinese Medicine approaches and aims to understand how the treatment works.
This study tests an herbal medicine (MLC1501) to see if it helps people recover better after a stroke. If you join, you'll take the medicine or a placebo (a pill with no active ingredient) while doing rehabilitation, and the study will track your recovery over time.
This study tests a daily supplement called NeuroAiD to see if it helps people recover after a mild or moderate stroke. It looks at how well patients feel and function in their daily life during recovery.
This study tests whether a medication called a GLP-1 receptor agonist (a type of drug used for diabetes) can improve recovery after a major stroke that was treated with a procedure to remove the blood clot. The goal is to see if this drug helps reduce further brain damage and improve outcomes.
Hear when a new Acute Ischemic Stroke AIS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.